Chairman Michael J. Farrell - 24 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Role: Chairman and CEO, Director
Signature: /s/ Michael J. Rider, attorney-in-fact for Mr. Farrell
Issuer symbol: RMD
Transactions as of: 24 Nov 2025
Net transactions value: +$8,339,310
Form type: 4
Filing time: 26 Nov 2025, 15:29:18 UTC
Previous filing: 24 Nov 2025
Next filing: 09 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Farrell Michael J.	Chairman and CEO, Director	RESMED INC., 9001 SPECTRUM CENTER BLVD, SAN DIEGO	/s/ Michael J. Rider, attorney-in-fact for Mr. Farrell	26 Nov 2025	0001485164

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RMD	ResMed Common Stock						466,223	24 Nov 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RMD	ResMed Common Stock Options	Award	$8,339,310	+33,288		$250.52	33,288	24 Nov 2025	ResMed Common Stock	33,288	$250.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the date on which options first become exercisable. The options vest in three equal annual installments commencing on November 11, 2026.